Viewing Study NCT03642067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-07-21 @ 4:21 AM
Study NCT ID: NCT03642067
Status: COMPLETED
Last Update Posted: 2025-06-15
First Post: 2018-08-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Microsatellite Stable (MSS) Colorectal Adenocarcinomas View
None Colorectal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relatlimab View
None Nivolumab View
None Immunotherapy View
None Anti-PD-1 View
None Anti-LAG-3 View
None Antibody View
None MSS View
None PD-L1 View
None Microsatellite stability View
None Colorectal cancer View
None Colon cancer View
None Rectal cancer View